Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

2.

Pollution exposure may affect lung cancer in women who have never smoked

3.

Healthy weight loss could lower your odds for cancer

4.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

5.

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot